Ascension Providence Hospital

Physician specializes in stem cell transplantation for blood cancers DETROIT, Jan. 7, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes José Larios, M.D., transplant hematologist. Dr. Larios is a member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos. He specializes in treating leukemia and lymphoma blood cancers, including Hodgkin and non-Hodgkin lymphomas. He began seeing patients at the Karmanos Cancer Center in Detroit in August 2024. Continue Reading José Larios, M.D., transplant hematologist, joined the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan. "Karmanos Cancer Institute is an NCI (National Cancer Institute)-Designated Comprehensive Cancer Center known for its expertise in treating solid and hematologic tumors," said Dr. Larios. "During my fellowship training, I was privileged to work with the incredible transplant and hematology teams, under the guidance and mentorship of Dr. Uberti in stem cell transplant and Dr. Yang in malignant hematology. I am now honored to be a part of the hematology and transplant team at the Barbara Ann Karmanos Cancer Institute." Dr. Larios has research and clinical interests in the role of bone marrow microenvironment in leukemia progression. This includes bone marrow signaling in acute leukemias, stem cell transplantation, and cellular therapy. He completed his postdoctoral fellowship in a breast oncology and pharmacology lab at the University of Michigan and investigated molecular mechanisms of endocrine resistance in hormone receptor-positive breast cancer. He recapitulated newly published mutations in the estrogen receptor gene using breast cancer cell lines as pre-clinical models. Additionally, Dr. Larios also examined mechanisms of resistance to CDK4/6 inhibitors. "With Karmanos being an NCI-Designated Comprehensive Cancer Center, in partnership with Wayne State University, Dr. Larios' research and interests will lead to significant discovery in the way we currently treat leukemias and lymphomas with stem cell transplantation," explained George Yoo, M.D., FACS, Chief Medical Officer at Karmanos Cancer Hospital. "Having physicians that push the standard of care needle forward is just what we need in the fight against cancer, to help with future treatments that cure cancers and lead to a better quality of life after treatment." In addition to his postdoctoral fellowship work, Dr. Larios completed an internal medicine residency at Ascension Providence Hospital in Southfield and received his medical degree at Ross University School of Medicine, which was in Dominica at that time. He is board-certified by the American Board of Internal Medicine, where he is also a diplomate in Internal Medicine. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Medical Association. He serves on the editorial board for the European Journal of Neurology and has co-authored multiple peer-reviewed published studies. View Dr. Lario's physician profile here. To request an appointment, visit karmanos.org or call 1-800-KARMANOS. About the Barbara Ann Karmanos Cancer Institute Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit . Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube. About the Bone Marrow & Stem Cell Transplantation Program at Karmanos The Karmanos Cancer Institute Bone Marrow Transplantation (BMT) Program is one of only a select group nationwide reporting some of the best survival outcomes for related and unrelated stem cell transplantation, according to data released yearly from the Center for International Blood and Marrow Transplant Registry. In addition, the BMT program has received full accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) – the highest level and the most extensive spectrum of accreditation offered by FACT for Bone Marrow Transplant Programs. Members of the BMT Team have vast experience in clinical research focusing on graft-versus-host disease and immunotherapy. To learn more, click here. SOURCE Karmanos Cancer Institute WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

Healthcare mergers and acquisitions are in no short supply as providers, retailers, health tech companies and other industry players look to expand their businesses and gain a competitive edge. Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry players look to expand their businesses and gain a competitive edge. Here’s a roundup of new deals that were revealed, closed, rumored or called off during the month of October. Providers UnityPoint Health and Presbyterian Healthcare Services called off plans for a cross-market merger. The entity would have spanned 48 hospitals with $11 billion in annual revenue. The systems did not share why they called off the deal, only noting to reporters that regulatory approvals didn’t play a role. However, the news came alongside word that UnityPoint President and CEO Clay Holderman would be leaving the organization. Henry Ford Health came together with several of Ascension Michigan’s hospitals and other facilities to form a joint venture with over $10.5 billion in annual operating revenue. The deal is expected to close in summer 2024 and create an entity with about 50,000 employees, 13 acute care hospitals and over 550 sites of care under the Henry Ford Health branding. The organizations stressed that their pending deal is “neither a merger nor an acquisition” with no cash transaction taking place. Aspirus Health and St. Luke’s Duluth took their merger plans a step forward with the signing of a definitive agreement. The tentative deal that was first announced back in July would yield a 19-hospital nonprofit. The agreement targets spring 2024 for a close, pending regulatory approvals, and outlines hundreds of millions of investments into St. Luke’s strategic projects. Minnesota Attorney General Keith Ellison said he is reviewing the deal. Prospect Medical Holdings agreed to sell off the struggling four-hospital Crozer Health in order to fend off litigation from the Pennsylvania attorney general’s office and a local nonprofit. The private equity firm had acquired Crozer in 2016 and sought to close a failing hospital, which the groups said it was required to operate until at least 2026. Prospect said it hired Morgan Stanley to advise on a sale that it expects to move forward within 60 days. UPMC (PDF) entered into a definitive integration and affiliation agreement with Washington Health Care Services. Per a notice, UPMC would appoint a third of the two-hospital system’s board once the deal is closed. The deal is still pending regulatory signoffs. Mountain Health Network, Marshall Health, Marshall University and an 80-member multispecialty physician group came together in a four-hospital academic health system dubbed Marshall Health Network, based in West Virginia. UC San Diego Health is purchasing Alvarado Hospital Medical Center from Prime Healthcare for $200 million. The organizations are aiming to close their deal before the end of the year. Parkview Health picked up two Ohio hospitals and an outpatient center in an affiliation deal that closed in early October. USA Health, the academic health system of the University of South Alabama, added the 349-bed Ascension Providence Hospital and its associated clinics. The system had purchased the facilities for $85 million. Yale New Haven Health acquired PhysicianOne Urgent Care, which operates 27 locations across Connecticut, Rhode Island, Massachusetts and New York. Payers Blue Cross and Blue Shield of North Carolina will acquire 55 FastMed locations in North Carolina for an undisclosed sum. Blue Cross NC, which has been a minority investor in FastMed since 2012, said it plans to invest in the locations to build on patient experience and access to critical services. The pending deal is expected to close in early 2024 pending approvals. Blue Cross Blue Shield of Vermont received an all-clear from its state’s regulators to become a subsidiary of Blue Cross Blue Shield of Michigan. The deal, unveiled back in May, is said to generate savings for the former company through shared contracts and vendors. The arrangement will also leave both organizations in charge of their respective governance, operations and policies. Froedtert Health is buying out Ascension’s 50% stake in Network Health, a Wisconsin health plan jointly run by the nonprofit health systems. The plan offers commercial and Medicare health insurance plans across 23 of the state’s counties and currently serves more than 117,000 members. Financial terms and a target closing window were not disclosed. Tech IKS Health, a company that provides administrative, clinical, operational and revenue tech solutions, acquired AQuity Solutions for $200 million to broaden its services from ambulatory care providers to hospitals. The resulting entity will have annual revenues of more than $330 million and an expanded workforce of more than 14,000 employees serving over 150,000 clinicians in many of the largest hospitals, health systems and specialty groups in the U.S. Olive AI, a healthcare automation unicorn, announced the sale of its remaining assets amid a shutdown of operations. Its clearinghouse and patient access business units were acquired by Waystar, while the prior authorization business unit has gone to Humata Health. MDLIVE, the telehealth arm of healthcare payer Cigna’s Evernorth, is acquiring Bright.md for an undisclosed sum. The deal will help MDLIVE launch asynchronous options for virtual urgent care in the coming year. Commure, which sells tech tools to health systems, unveiled a deal to merge with healthcare workflow automation software maker Athelas by the end of October. The combined company will have about 800 employees with plans to scale up thanks to a $70 million investment from General Catalyst that puts the combined entity at a reported valuation of $6 billion. Other financial terms of the deal were not disclosed. Access Healthcare, a tech-enabled revenue cycle management and healthcare services firm, acquired patient engagement services company Envera Health to broaden its portfolio of capabilities. Terms were not disclosed. WellSky, a software and services vendor, picked up post-acute care tech services firm Corridor from HealthEdge Investment Partners. The deal, for which financial details were not disclosed, will help WellSky expand its medical coding and revenue cycle management offerings. Vizient acquired PrefTech OR, a preference card management software maker serving providers, for an undisclosed sum. The American Health Information Management Association acquired HCPro, which offers educational and compliance-related revenue cycle management products and services, from its parent company Simplify Compliance. The nonprofit association will be operating HCPro as a for-profit, wholly owned subsidiary.

Providence Hospital will be known as USA Health Providence Hospital. The University of South Alabama today announced that Providence Hospital and its clinics are now part of USA Health, the University’s academic health system. The completion of the acquisition comes six months after the University of South Alabama Health Care Authority reached an agreement with St. Louis-based Ascension to acquire Providence Hospital and its clinics. Providence Hospital, a fixture in west Mobile, will be known as USA Health Providence Hospital. USA President Jo Bonner welcomed Providence to the University of South Alabama family. “We already share core values and a commitment to provide compassionate care to those who need it most,” Bonner said. “With your help, we will build upon our reputation for providing exceptional healthcare, education and research that transforms medicine in the Gulf Coast region.” The acquisition includes Providence’s 349-bed hospital, eight clinics on the hospital campus and six family practice sites in west and north Mobile and Moss Point, Mississippi. An estimated 1,800 Providence associates, physicians and other providers are now part of USA Health. “We are very excited to welcome everyone at Providence to USA Health,” said Dr. John V. Marymont, vice president for medical affairs and dean of USA’s Frederick P. Whiddon College of Medicine. “To those who are graduates of the University or the medical school, we proudly say, ‘Welcome home.’” USA Health and Providence have worked diligently to ensure a seamless transition for patients, physicians and associates. There will be no disruption in services or procedures. Todd Kennedy, who led Providence under Ascension, will serve as the hospital’s chief executive officer. USA Health officials praised Providence’s excellent reputation and decades of service to the community. “Providence is well known for its rich history and culture, and we look forward to continuing that,” said Owen Bailey, chief executive officer for USA Health and senior associate vice president for medical affairs. “I have personally witnessed a great deal of excitement at both Providence and USA Health about our future together.” USA Health is nationally recognized for its Level I trauma center, comprehensive stroke center, burn center, Level III NICU, center for maternal-fetal medicine and cancer treatment. Providence Hospital joins USA Health University Hospital and USA Health Children’s & Women’s Hospital as its third inpatient care facility. The acquisition also increases the number of USA Health’s locations from 29 to 44.